If you need more information or have any questions, please contact Jamal El-Mosleh, CEO.
Phone: +46(0)703 31 90 51
The following sections contain information that are relevant for Elicera's corporate governance.Articles of AssociationGeneral MeetingBoardManagementAuditorCertified Adviser
Elicera Therapeutics is listed on Nasdaq First North Growth Market. The company has issued one class of shares and the total number of shares amounts to 19 782 000.